Samsung Ventures

Samsung Ventures is the corporate venture arm of Samsung Electronics and operates from Seoul as one of the most active CVCs globally, with a mandate that spans semiconductors, displays, AI, and a meaningful healthcare practice anchored in medical devices, digital health, and AI in healthcare. The firm has been investing for more than two decades and has built a portfolio that includes many companies whose technology either feeds Samsung’s own product roadmap or extends the parent’s reach into adjacent categories.

The healthcare thesis is shaped by Samsung’s strategic interests in connected health, wearables, and medical imaging, but the firm also makes financially driven investments in areas like AI foundation models, drug discovery platforms, and digital therapeutics where the strategic linkage is looser. Recent activity has emphasized AI infrastructure and applied AI in clinical settings, reflecting Samsung’s broader bet on generative and predictive AI across its product lines. The portfolio mix balances early-stage technical bets with later-stage participation in companies whose products Samsung might license, distribute, or partner with at scale.

Check sizes typically range from one to five million dollars, with the firm investing from seed through Series C. Geographic footprint is global, though the team has particular density in Korea, the US, Israel, and selectively China. Samsung Ventures is comfortable as a co-investor with both independent VCs and other corporate investors, and the firm has historically been disciplined about not requiring exclusivity or right of first refusal arrangements that might constrain a portfolio company’s strategic options.

The team is structured around regional offices and sector specialists, which means healthcare deals are typically reviewed by professionals with relevant industry backgrounds rather than generalists rotating through assignments. Decision-making moves through committee but the firm’s scale and experience keep that process predictable for prepared founders.

For founders, Samsung Ventures is most useful when the strategic relationship with Samsung Electronics is concretely valuable rather than nominal. That includes companies building on Samsung hardware platforms, working in adjacencies to Samsung’s healthcare devices and wearables, or developing AI capabilities that could integrate with Samsung’s research roadmap. Post-investment engagement varies by deal but typically includes an observer seat, periodic strategic check-ins, and selective introductions to Samsung business units when there is an obvious pilot or partnership opportunity. Founders should negotiate carefully on information rights and any strategic clauses, since CVC documents can drift toward parent-favorable defaults. For medical device, digital health, and AI in healthcare founders globally who want a sophisticated corporate venture partner with real engineering depth and a long-term horizon, Samsung Ventures is among the more credible CVCs to engage, particularly when the company’s roadmap intersects with Samsung’s own product trajectory in a way that makes the strategic interest mutual rather than one-directional.